![Fabrice Chouraqui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fabrice Chouraqui
Chief Executive Officer at
PHARMING GROUP N.V.
Net worth: 221 838 $ as of 30/06/2026
Profile
Fabrice Chouraqui is currently Chief Executive Officer & Executive Director at Pharming Group NV since 2025 and serves as an Independent Member on the Governors Board at Orano Med SAS. Former roles include Chief Executive Officer & Director at Cellarity Inc. and President at Novartis Pharmaceuticals Corp.
from 2016 to 2019.
Education includes an MBA from INSEAD and graduate and doctorate degrees from Universite Paris Cite.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARMING GROUP NV 0.02% | 31/03/2026 | 161,425 ( 0.02% ) | 221 838 $ | 30/06/2026 |
Fabrice Chouraqui active positions
| Companies | Position | Start |
|---|---|---|
| PHARMING GROUP N.V. | Chief Executive Officer | 04/03/2025 |
Orano Med SAS
 Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Director/Board Member | - |
Former positions of Fabrice Chouraqui
| Companies | Position | End |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | President | 01/01/2019 |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Chief Executive Officer | 12/05/2025 |
Training of Fabrice Chouraqui
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
- Stock Market
- Insiders
- Fabrice Chouraqui
Choose MarketScreener 
